SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Splash Beverage Group Inc (SBEV) News

Track canonical SquawkNews coverage tagged to SBEV, Splash Beverage Group Inc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol SBEV Asset equity Sector Markets 90 days 13 Last 0.4622 Updated Aug 25, 2026, 12:32 PM UTC Open live news feed
L Endovia Health Sciences hits first FDA milestone for CannEpil vet program Endovia Health Sciences (formerly Splash Beverage) says it achieves its first FDA regulatory milestone for its CannEpil veterinary development program. REGULATION | Aug 25, 2026, 12:32 PM UTC M Splash Beverage Group to become Endovia Health Sciences, ticker EDVA Monday Splash Beverage Group says it will become Endovia Health Sciences and its NYSE American ticker will change to EDVA effective Monday. MNA | Aug 21, 2026, 12:38 PM UTC L SBEV reports second-quarter 2026 results, strategic transformation Splash Beverage reports second-quarter 2026 results and highlights its strategic transformation toward Endovia Health Sciences. EARNINGS | Aug 20, 2026, 01:00 PM UTC L SBEV to Rebrand as Endovia Health Sciences SBEV is rebranding as Endovia Health Sciences MNA | Aug 12, 2026, 02:03 PM UTC L SBEV - Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway - C SBEV - Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway REGULATION | Aug 05, 2026, 12:31 PM UTC L SBEV - Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA -Regulated Pharmaceutical Deve SBEV - Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA -Regulated Pharmaceutical Development Program REGULATION | Jul 29, 2026, 12:31 PM UTC L SBEV splash Beverage group announces significant balance sheet improvement and board approval of reverse stock split as company continues st SBEV splash Beverage group announces significant balance sheet improvement and board approval of reverse stock split as company continues strategic transformation Splash Beverage group - settles $3.3M liabilities for $55 EQUITY | Jul 14, 2026, 12:46 PM UTC H Crude Oil Moves Higher; Rivian Automotive Shares Plunge U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.33% to 52,882.93 while the NASDAQ fell 0.61% RATES | Jul 07, 2026, 05:06 PM UTC H Dow Gains Over 200 Points; US Trade Deficit Widens In May U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.39% to 53,261.78 while the NASDAQ fell 0.52% to 25,985.50 RATES | Jul 07, 2026, 01:41 PM UTC L Splash Beverage enters licensing agreement with Argent BioPharma for CannEpil Splash Beverage announced that it has entered into an exclusive global licensing agreement with Argent BioPharma for CannEpil, a proprietary, patent protected cannabinoid-based investigational therapeutic approved for th REGULATION | Jul 07, 2026, 10:22 AM UTC L US Companies Moving the Markets, Morning edition Mon, Jul 06, 2026 as of 10.00 am ET A look at the top 10 most actives in the United States LQR House Inc. (YHC) fell 9.1% to $0.041 on volume of 333,214,384 shares Splash Beverage Group Inc. (NV) EQUITY | Jul 06, 2026, 02:01 PM UTC L Splash Beverage Acquires Exclusive Global Rights for Epilepsy Therapy CannEpil () -- Splash Beverage (SBEV) said Monday it has signed an agreement with Argent BioPharma to acquire exclusive global licensing for an initial 20-year term for CannEpil, a cannabinoid-based investigational therapeutic fo EARNINGS | Jul 06, 2026, 01:18 PM UTC L Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engag FORT LAUDERDALE, Fla., July 06, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE A REGULATION | Jul 06, 2026, 12:31 PM UTC